Faron's Financial Statement Release January 1 to December 31

TURKU, Finland and BOSTON, March 13, 2024 -- Faron Pharmaceuticals Ltd. , a clinical-stage biopharmaceutical company focused on tackling cancers via novel myeloid cell targeted immunotherapies,...

Related Keywords

Boston , Massachusetts , United States , Jukka , Lapland , Finland , Washington , Fred Hutchinson Cancer Research Center , Seattle , Finnish , American , Jo Turner , Christine Roth , James Obrien , Leopoldo Zambeletti , Sandy Jamieson , Juha Karttunen , David Daley , Gregoryb Brown , Mary Jane Elliott , Markku Jalkanen , Birge Berns , Christopher Golden , Lindsey Neville , Anne Whitaker , Frank Armstrong , Cairn Financial Advisers , Johnson , Drug Administration , Globenewswire Inc , Faron Pharmaceuticals Ltd , American Association For Cancer Research Annual Meeting , Sanofi Aventis , International Accounting Standard , European Hematology Association , Seagen Inc , Faron Pharmaceuticals Oy , European Hematology Association Congress , Faron Pharmaceuticals Ltd As Borrower Facilities Agreement , American Society Of Hematology , Peel Hunt , Finnish Companies , Directors Of The Company , First North , Orphan Drug Designation , Cell Reports , Chief Executive Officer , Annual Meeting , Hematology Association Congress , Cancer Research Annual Meeting , Hutchinson Cancer Research Center , Chief Financial , Non Executive Directors , Chief Medical Officer , Executive Vice President , Non Executive Director , Chief Medical , Facilities Agreement , Director Proposal , Annual General Meeting , Chief Financial Officer , Jane Elliott , Certified Adviser , Nasdaq First , Hematology Association , Cell Reports Medicine , Faron Board Member , Interim Chief Medical , Financial Statements , Capital Loan , Finnish Companies Act , Investment Round , Due Date , Final Due Date , Extraordinary General Meeting , Income Statement , Balance Sheet , Cash Flow Statement ,